Scholtz & Company’s Albemarle ALB Stock Holding History

Scholtz & Company’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-35,185	Closed	-$4.5M	–	60
2017 Q4	$4.5M	Buy	35,185 +850	+2%	+$115K	3.26%	11
2017 Q3	$4.68M	Buy	+34,335	New	+$4.08M	3.66%	6

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

GXMC

Global X Management Company New York $5.62B AUM 10.7% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Scholtz & Company's ALB Position: Q1 2018 in Review

Scholtz & Company sold out of Albemarle (ALB) in Q1 2018, closing a stake of 35,185 shares — an estimated $4.5M sold.

Scholtz & Company first reported a position in ALB in Q3 2017 and held it in 2 quarters. The position peaked at $4.68M in Q3 2017. 563 funds tracked by Wall St. Rank hold ALB as of Q1 2018.

Scholtz & Company reported no remaining Albemarle position as of Q1 2018 after selling out during the quarter.
Scholtz & Company sold 35,185 Albemarle shares in Q1 2018, an estimated $4.5M.
Scholtz & Company first reported a position in Albemarle in Q3 2017 and held it in 2 quarters.
Scholtz & Company's Albemarle position peaked at $4.68M in Q3 2017.
563 funds tracked by Wall St. Rank held Albemarle as of Q1 2018.

Based on Scholtz & Company's 13F filing for Q1 2018, filed 11 May 2018.